Showing results (271-280 of 330) with videos related to

Sort By:
Pageof 33
Journal of Natural Products|April 16, 2010
Hypopigmentary action of dihydropyranocoumarin D2, a decursin derivative, as a MITF-degrading agentDong-Seok Kim, So-Hee Park, Hyun-Kyung Lee, et al.
Phytotherapy Research : PTR|April 24, 2013
Hypopigmentary effects of ethyl P-methoxycinnamate isolated from Kaempferia galangaHyun-Ju Ko, Hae Jong Kim, Su Yeon Kim, et al.
The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology|July 1, 2014
KHG26792 Inhibits Melanin Synthesis in Mel-Ab Cells and a Skin Equivalent ModelHailan Li, Jandi Kim, Hoh-Gyu Hahn, et al.
Biological & Pharmaceutical Bulletin|January 5, 2007
A new 2-imino-1,3-thiazoline derivative, KHG22394, inhibits melanin synthesis in mouse B16 melanoma cellsDong-Seok Kim, Yun-Mi Jeong, Ik-Kyu Park, et al.
Die Pharmazie|May 16, 2015
Methyl gallate from Acer barbinerve decreases melanin synthesis in Mel-Ab cellsIn Wook Kim, Hyo-Soon jeong, Jin Kyu Kim, et al.
Biochemical and Biophysical Research Communications|August 3, 2025
Monoterpenoid fluorophthalimide IMiDs that lack human cereblon binding: synthesis and anti-proliferative, anti-angiogenic and anti-inflammatory activitiesWeiming Luo, Kathleen M Garchitorena, David Tweedie, et al.
International Journal of Nanomedicine|November 27, 2025
Enhanced Bioavailability of a Thionated IMiD Derivative Nanosuspension for Parkinson's Disease Targeting α-SynucleinLuca Casula, Maria Francesca Palmas, Maria Cristina Cardia, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|March 27, 2012
The clinical features and surgical outcomes of pediatric patients with primary spinal cord tumorGwi Hyun Choi, Jae Keun Oh, Tae Yup Kim, et al.
Neuron|June 26, 2018
Brain Somatic Mutations in MTOR Disrupt Neuronal Ciliogenesis, Leading to Focal Cortical DyslaminationSang Min Park, Jae Seok Lim, Suresh Ramakrishina, et al.
Biomedicines|October 27, 2022
Activity of a Novel Anti-Inflammatory Agent F-3,6'-dithiopomalidomide as a Treatment for Traumatic Brain InjuryShih Chang Hsueh, Michael T Scerba, David Tweedie, et al.
Pageof 33